45 related articles for article (PubMed ID: 37545790)
21. Five-Year Survival Outcomes From the PACIFIC Trial: Durvalumab After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer.
Spigel DR; Faivre-Finn C; Gray JE; Vicente D; Planchard D; Paz-Ares L; Vansteenkiste JF; Garassino MC; Hui R; Quantin X; Rimner A; Wu YL; Özgüroğlu M; Lee KH; Kato T; de Wit M; Kurata T; Reck M; Cho BC; Senan S; Naidoo J; Mann H; Newton M; Thiyagarajah P; Antonia SJ
J Clin Oncol; 2022 Apr; 40(12):1301-1311. PubMed ID: 35108059
[TBL] [Abstract][Full Text] [Related]
22. Elevated Coronary Artery Calcium Quantified by a Validated Deep Learning Model From Lung Cancer Radiotherapy Planning Scans Predicts Mortality.
Atkins KM; Weiss J; Zeleznik R; Bitterman DS; Chaunzwa TL; Huynh E; Guthier C; Kozono DE; Lewis JH; Tamarappoo BK; Nohria A; Hoffmann U; Aerts HJWL; Mak RH
JCO Clin Cancer Inform; 2022 Jan; 6():e2100095. PubMed ID: 35084935
[TBL] [Abstract][Full Text] [Related]
23. Mean Heart Dose Is an Inadequate Surrogate for Left Anterior Descending Coronary Artery Dose and the Risk of Major Adverse Cardiac Events in Lung Cancer Radiation Therapy.
Atkins KM; Bitterman DS; Chaunzwa TL; Kozono DE; Baldini EH; Aerts HJWL; Tamarappoo BK; Hoffmann U; Nohria A; Mak RH
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1473-1479. PubMed ID: 33713743
[TBL] [Abstract][Full Text] [Related]
24. Statin Use, Heart Radiation Dose, and Survival in Locally Advanced Lung Cancer.
Atkins KM; Bitterman DS; Chaunzwa TL; Williams CL; Rahman R; Kozono DE; Baldini EH; Aerts HJWL; Tamarappoo BK; Hoffmann U; Nohria A; Mak RH
Pract Radiat Oncol; 2021; 11(5):e459-e467. PubMed ID: 33476841
[TBL] [Abstract][Full Text] [Related]
25. Association of Left Anterior Descending Coronary Artery Radiation Dose With Major Adverse Cardiac Events and Mortality in Patients With Non-Small Cell Lung Cancer.
Atkins KM; Chaunzwa TL; Lamba N; Bitterman DS; Rawal B; Bredfeldt J; Williams CL; Kozono DE; Baldini EH; Nohria A; Hoffmann U; Aerts HJWL; Mak RH
JAMA Oncol; 2021 Feb; 7(2):206-219. PubMed ID: 33331883
[TBL] [Abstract][Full Text] [Related]
26. Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions.
Banfill K; Giuliani M; Aznar M; Franks K; McWilliam A; Schmitt M; Sun F; Vozenin MC; Faivre Finn C;
J Thorac Oncol; 2021 Feb; 16(2):216-227. PubMed ID: 33278607
[TBL] [Abstract][Full Text] [Related]
27. Optimizing Cardiovascular Health in Patients With Cancer: A Practical Review of Risk Assessment, Monitoring, and Prevention of Cancer Treatment-Related Cardiovascular Toxicity.
Dent SF; Kikuchi R; Kondapalli L; Ismail-Khan R; Brezden-Masley C; Barac A; Fradley M
Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-15. PubMed ID: 32213102
[TBL] [Abstract][Full Text] [Related]
28. Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.
Bradley JD; Hu C; Komaki RR; Masters GA; Blumenschein GR; Schild SE; Bogart JA; Forster KM; Magliocco AM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Koprowski CD; Olson MR; Meng J; Paulus R; Curran WJ; Choy H
J Clin Oncol; 2020 Mar; 38(7):706-714. PubMed ID: 31841363
[TBL] [Abstract][Full Text] [Related]
29. Cardiac Radiation Dose, Cardiac Disease, and Mortality in Patients With Lung Cancer.
Atkins KM; Rawal B; Chaunzwa TL; Lamba N; Bitterman DS; Williams CL; Kozono DE; Baldini EH; Chen AB; Nguyen PL; D'Amico AV; Nohria A; Hoffmann U; Aerts HJWL; Mak RH
J Am Coll Cardiol; 2019 Jun; 73(23):2976-2987. PubMed ID: 31196455
[TBL] [Abstract][Full Text] [Related]
30. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett DK; Blumenthal RS; Albert MA; Buroker AB; Goldberger ZD; Hahn EJ; Himmelfarb CD; Khera A; Lloyd-Jones D; McEvoy JW; Michos ED; Miedema MD; Muñoz D; Smith SC; Virani SS; Williams KA; Yeboah J; Ziaeian B
Circulation; 2019 Sep; 140(11):e596-e646. PubMed ID: 30879355
[No Abstract] [Full Text] [Related]
31. Radiation Therapy Is Associated With an Increased Incidence of Cardiac Events in Patients with Small Cell Lung Cancer.
Ferris MJ; Jiang R; Behera M; Ramalingam SS; Curran WJ; Higgins KA
Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):383-390. PubMed ID: 30191870
[TBL] [Abstract][Full Text] [Related]
32. Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology.
Kostakou PM; Kouris NT; Kostopoulos VS; Damaskos DS; Olympios CD
Heart Fail Rev; 2019 Jan; 24(1):91-100. PubMed ID: 30073443
[TBL] [Abstract][Full Text] [Related]
33. A cardiac contouring atlas for radiotherapy.
Duane F; Aznar MC; Bartlett F; Cutter DJ; Darby SC; Jagsi R; Lorenzen EL; McArdle O; McGale P; Myerson S; Rahimi K; Vivekanandan S; Warren S; Taylor CW
Radiother Oncol; 2017 Mar; 122(3):416-422. PubMed ID: 28233564
[TBL] [Abstract][Full Text] [Related]
34. Heart Dose Is an Independent Dosimetric Predictor of Overall Survival in Locally Advanced Non-Small Cell Lung Cancer.
Speirs CK; DeWees TA; Rehman S; Molotievschi A; Velez MA; Mullen D; Fergus S; Trovo M; Bradley JD; Robinson CG
J Thorac Oncol; 2017 Feb; 12(2):293-301. PubMed ID: 27743888
[TBL] [Abstract][Full Text] [Related]
35. Radiation-induced heart disease in lung cancer radiotherapy: A dosimetric update.
Ming X; Feng Y; Yang C; Wang W; Wang P; Deng J
Medicine (Baltimore); 2016 Oct; 95(41):e5051. PubMed ID: 27741117
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of Preexisting Cardiovascular Disease in Patients With Different Types of Cancer: The Unmet Need for Onco-Cardiology.
Al-Kindi SG; Oliveira GH
Mayo Clin Proc; 2016 Jan; 91(1):81-3. PubMed ID: 26602599
[TBL] [Abstract][Full Text] [Related]
37. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards).
Hicks KA; Tcheng JE; Bozkurt B; Chaitman BR; Cutlip DE; Farb A; Fonarow GC; Jacobs JP; Jaff MR; Lichtman JH; Limacher MC; Mahaffey KW; Mehran R; Nissen SE; Smith EE; Targum SL
J Am Coll Cardiol; 2015 Jul; 66(4):403-69. PubMed ID: 25553722
[No Abstract] [Full Text] [Related]
38. Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer.
Feng M; Moran JM; Koelling T; Chughtai A; Chan JL; Freedman L; Hayman JA; Jagsi R; Jolly S; Larouere J; Soriano J; Marsh R; Pierce LJ
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):10-8. PubMed ID: 20421148
[TBL] [Abstract][Full Text] [Related]
39. Radiation dose-volume effects in the heart.
Gagliardi G; Constine LS; Moiseenko V; Correa C; Pierce LJ; Allen AM; Marks LB
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3 Suppl):S77-85. PubMed ID: 20171522
[TBL] [Abstract][Full Text] [Related]
40. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation.
Pencina MJ; D'Agostino RB
Stat Med; 2004 Jul; 23(13):2109-23. PubMed ID: 15211606
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
